Safety of IBD drugs during pregnancy and breastfeeding
Part of Digestive system, Women’s health & pregnancy clinical trials.
This study looks at how safe certain IBD medications are when taken during pregnancy and while breastfeeding. It follows mothers and their babies to check for any health effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with inflammatory bowel disease (IBD)
- You are pregnant
- You are being treated with certain advanced IBD drugs, such as JAK inhibitors or S1P receptor modulators (but not anti-TNF drugs like infliximab or adalimumab)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study tracks outcomes for mothers with inflammatory bowel disease (IBD) and their babies during pregnancy and breastfeeding while using IBD medicines. It aims to better understand the safety of these medicines so future pregnancies can be managed more confidently.
This study looks at how pregnancy and newborn outcomes turn out for people with inflammatory bowel disease (IBD) who are pregnant and taking immune-suppressing medicines or biologic therapies. It may help doctors better understand risks and care for mothers and babies in similar situations.
This study is a registry that collects information from pregnant people with inflammatory bowel disease. By joining, you help researchers understand how IBD and treatments affect pregnancy and baby health.
This study looks at how special nutritional support during pregnancy helps women with IBD (a chronic digestive condition) and their babies. Researchers will track the health of both mother and baby to see if better nutrition improves outcomes.
This trial looks at how pregnancy affects and is affected by inflammatory bowel disease. It aims to learn more to help women with IBD who are or want to become pregnant.
This study looks at gut health in pregnant women with and without inflammatory bowel disease (IBD). It tracks a protein called calprotectin in stool samples, along with diet and baby health, to learn how IBD affects pregnancy and infant development.
Hear when a new Drusgs for IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.